Breastfeeding, triple ARV prophylaxis, and MTCT prevention

The Lancet Infectious Diseases

Volumn 11, Issue 3, 2011, Pages 154-155

  Becquet, Renaud ^a,b   Ekouevi, Didier K ^b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c University Hospital of Treichville   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

BREAST FEEDING; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; LETTER; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SINGLE DRUG DOSE; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 79952039899     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70299-1     Document Type: Letter

References (12)

1. Mofenson LM Antiretroviral drugs to prevent breastfeeding HIV transmission. Antivir Ther 2010, 15:537-553.
2. Rollins NC, Becquet R, Bland RM, Coutsoudis A, Coovadia HM, Newell ML Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritisation within programs. AIDS 2008, 22:2349-2357.
3. Becquet R, Ekouevi DK, Arrive E, et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009, 49:1936-1945.
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet InfectDis 2011, The Kesho Bora Study Group, published online Jan 14. 10.1016/S1473-3099(10)70288-7.
5. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010, 362:2271-2281.
6. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010, 362:2282-2294.
7. Recommendations for use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings WHO, (accessed Dec 8, 2010). http://www.who.int/hiv/pub/mtct/guidelines/en/.
8. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008, 372:300-313. Six Week Extended-Dose Nevirapine (SWEN) Study Team.
9. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006, 296:794-805.
10. Hargrove J, Humphrey J Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe. AIDS 2010, 24:F11-F14. Zvitambo study group.
11. Schouten E. Making it happen: revising national policies to reflect changes in WHO recommendations for preventing vertical transmission of HIV (In satellite session "Understanding the revised WHO recommendations") The XVIII International AIDS Conference; July 18-23, 2010; Vienna, Austria.
12. Barnighausen T, Bloom DE, Humair S Universal antiretroviral treatment: the challenge of human resources. Bull World Health Organ 2010, 88:951-952.